Orgenesis Inc. (ORGS)
2.50
-0.10 (-3.85%)
At close: Apr 04, 2025, 3:49 PM
-3.85% (1D)
| Bid | 2.5 |
| Market Cap | 12.93M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -24.46 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | 2.21 |
| Analyst | n/a |
| Ask | 2.5 |
| Volume | 4,363 |
| Avg. Volume (20D) | 12,763 |
| Open | 2.56 |
| Previous Close | 2.60 |
| Day's Range | 2.31 - 2.56 |
| 52-Week Range | 0.87 - 10.80 |
| Beta | 0.89 |
About ORGS
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing ...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 13, 2012
Employees 146
Stock Exchange OTC
Ticker Symbol ORGS
Website https://www.orgenesis.com
6 months ago
-25%
Orgenesis shares are trading lower after the compa...
Unlock content with
Pro Subscription
7 months ago
+11.11%
Orgenesis shares are trading higher after the company announced a joint venture with Harley Street Healthcare Group to launch a longevity & wellness initiative. HSHG will invest $10 million into the company and venture.
2 months ago · accessnewswire.com
Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture HoldingsFunding Aimed at Accelerating Rollout of Decentralized CGT Platform GERMANTOWN, MD / ACCESS Newswire / January 28, 2025 / Orgenesis Inc . (OTCQX:ORGS) ("Orgenesis" or the "Company"), a global biotech ...